Academics


Faculty Directory

Home > Academics > Faculty Directory

Lee, Yong Sun

Name
Lee, Yong Sun(full-time professor)
Faculty Appointment
(title, department)
Professor, Department of Cancer Biomedical Science

Area of Expertise
non-coding RNAs
Contact no
+82-31-920-2748
E-mail
yslee@ncc.re.kr, lee.yongsun.go@gmail.com
Previous Appointment(s) Held
Assistant Professor (tenure track), Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX
Educational Background
03/1995-08/1998
Department of Microbiology, Seoul National University, Seoul, Korea
Advisor: Dr. Deog Su Hwang
(Ph.D. thesis: Interaction of DnaA and IciA Protein with dnaA Gene Promoter from Escherichia coli)

03/1993-02/1995
Department of Microbiology Seoul National University, Seoul, Korea
Advisor: Dr. Deog Su Hwang
(M.S. thesis: Transcriptional Activation of dnaA Gene by IciA Protein)

03/1988-02/1993
Department of Microbiology, Seoul National University, Seoul, Korea
Research Interests (Please place in paragraph form)
My long-term goal is to expand the knowledge of ncRNAs. Particularly, small ncRNAs of “regulatory” function are one of the most important discoveries in recent years and the focus of the current research, as exemplified by two representative classes - miRNAs and siRNAs. These regulatory RNAs are involved in almost all fundamental aspects of biology – cancer, development, proliferation and apoptosis, immune responses, etc. Besides miRNAs and siRNAs, several other types of ncRNAs have also been (and are still being) identified. I have identified two novel types of ncRNAs: tRFs (tRNA-derived RNA Fragments) and nc886 (non-coding RNA 886). At the present time my main focus is on nc886. nc886 is a potent tumor suppressor and immune modulator. It has a significant impact on cell proliferation and plasticity by interacting with several proteins such as PKR (protein kinase R), Dicer, -catenin, etc and by modulating the fundamental pathways in which they are involved. nc886’s expression pattern in diverse types of cancer (so far including esophageal cancer, gastric cancer, liver cancer, and breast cancer) indicates its diagnostic utility in those tumors. Both tRFs and nc886 are highly novel molecules and have a potential to become breakthrough discoveries with future clinical applications.
International Collaboration
- Dr. Xiaoyong Bao at Department of Pediatrics (The role of miRNAs and tRFs in respiratory syncytial virus infection)
- Dr. Bin Gong at Department of Pathology (The role of miRNAs and tRFs in pathogenesis of Rickettsia conorii)
- Dr. Thomas G Ksiazek at Sealy Center for Vaccine Development and Dr. Bin Gong at Department of Pathology (The role of miRNAs and tRFs in BSL4 viruses)
- Dr. Minkyung Yi at Department of Microbiology and Immunology (The role of nc886 in HCV infection)
- Dr. Junji Iwahara at Department of Biochemistry and Molecular Biology (Protein NMR in tissue culture fluids)
- Dr. Robert A. Waterland at Baylor College of Medicine (epigenetic regulation of nc886 and its impact on PKR)
- Dr. Robert G. Roeder at the Rockefeller University (in vitro study on nc886 expression)
- Dr. Suebpong Tanasanvimon and Dr. Milind Javle at MD Anderson Cancer Center (nc886 in cholangiocarcinoma)
- Dr. Hyun-Sung Lee at Baylor College of Medicine (nc886 in esophageal cancer and hepatoma)
- Ju-Seog Lee at MD Anderson Cancer Center (nc886 in esophageal cancer and hepatoma)
- Dr. Inhan Lee at miRcore, MI (miBridge model for miRNA-target interaction)
- Dr. Stacy Horner at Duke University (nc886 and HCV)
- Dr. Thomas Westbrook at Baylor College of Medicine (nc886 in the MYC pathway)
- Dr. Chanvit Leelayuwat at Khon Khan University, Thailand (nc886 in cholangiocarcinoma)
- Dr. Zdenko Herceg at International Agency for Research on Cancer, France (epigenetic regulation of nc886 in cholangiocarcinoma)
- Dr. Amonrat Jumnainsong at Khon Khan University, Thailand (nc886 in Dengue virus infection)
Achievements
ARTICLES IN PEER-REVIEWED JOURNALS: [journal impact factor; # cited as of Jan 31, 2017]

1. Park J-L, Lee YS, Song M-J, Hong S-H, Ahn J-H, Seo E, Shin S-P, Lee S-J, Johnson BH, Stampfer MR, Kim H-P, Kim S-Y, Lee YS, (2017) Epigenetic regulation of RNA polymerase III transcription in early breast tumorigenesis. Oncogene (in press) [7.932; 0]

2. Lee EK, Hong SH, Shin S, Lee HS, Lee JS, Park EJ, Choi SS, Min JW, Park D, Hwang JA, Johnson BH, Jeon SH, Kim IH, Lee YS, Lee YS (2016) nc886, a non-coding RNA and suppressor of PKR, exerts an oncogenic function in thyroid cancer. Oncotarget 7(46): 75000-75012 [5.008; 0]

3. Deng J, Ptashkin RN, Chen Y, Cheng Z, Liu G, Phan T, Deng X, Zhou J, Lee I, Lee YS*, Bao X* (2015) Respiratory syncytial virus utilizes a tRNA fragment to suppress antiviral responses through a novel targeting mechanism. Mol Ther 23(10):1622-1629 (* co-corresponding authors) [6.227; 11]

4. Silver MJ, Kessler NJ, Hennig BJ, Dominguez-Salas P, Laritsky E, Baker MS, Coarfa C, Hernandez-Vargas H, Castelino JM, Routledge MN, Gong YY, Herceg Z, Lee YS, Lee K, Moore SE, Fulford AJ, Prentice AM, Waterland RA (2015) Independent genomewide screens identify the tumor suppressor VTRNA2-1 as a human epiallele responsive to periconceptional environment. Genome Biol 16: 118 [10.810; 28]

5. Lee H-S, Lee K, Jang H-J, Lee GK, Park J-L, Kim S-Y, Kim S-B, Johnson BH, Zo JI, Lee J-S*, Lee YS* (2014) Epigenetic silencing of the non-coding RNA nc886 provokes oncogenes during human esophageal tumorigenesis. Oncotarget 5(11): 3472-3481 (* co-corresponding authors) [6.627; 13]

6. Lee K-S, Park J-L, Lee K, Richardson LE, Johnson BH, Lee H-S, Lee J-S, Kim S-B, Kwon O-H, Song KS, Kim YS, Ashktorab H, Smoot DT, Jeon SH*, Kim S-Y*, Lee YS* (2014) nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancer. Oncotarget 5(11): 3944-3955 (* co-corresponding authors) [6.627; 13]

7. Gong B*, Lee YS*, Lee I, Shelite TR, Kunkeaw N, Xu G, Lee K, Jeon SH, Johnson BH, Chang Q, Ha T, Mendell NL, Cheng X, Bouyer DH, Boor PJ, Ksiazek TG, Walker DH (2013) Compartmentalized, functional role of angiogenin during spotted fever group rickettsia-induced endothelial barrier dysfunction: evidence of possible mediation by host tRNA-derived small noncoding RNAs. BMC Infect Dis 13: 285 (* co-corresponding authors) [3.025; 7]

8. Wang Q, Lee I, Ren J, Ajay SS, Lee YS*, Bao X* (2013) Identification and functional characterization of tRNA-derived RNA fragments (tRFs) in respiratory syncytial virus infection. Mol Ther 21(2): 368-379 (* co-corresponding authors) [7.041; 62]

9. Kunkeaw N, Jeon SH, Lee K, Johnson BH, Tanasanvimon S, Javle M, Pairojkul C, Chamgramol Y, Wongfieng W, Gong B, Leelayuwat C, Lee YS (2013) Cell death/proliferation roles for nc886, a non-coding RNA, in the Protein Kinase R pathway in cholangiocarcinoma. Oncogene 32(32): 3722–3731 [7.357; 24] - featured on www.MDLinx.com

10. Jeon SH, Lee K, Lee KS, Kunkeaw N, Johnson BH, Holthauzen LM, Gong B, Leelayuwat C, Lee YS (2012) Characterization of the direct physical interaction of nc886, a cellular non-coding RNA, and PKR. FEBS Lett 586(19): 3477–3484 [3.538; 18]

11. Lee K, Kunkeaw N, Jeon SH, Lee I, Johnson BH, Kang GY, Bang JY, Park HS, Leelayuwat C, Lee YS (2011) Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity. RNA 17(6): 1076-1089 [6.051; 57]

12. Lee YS*, Shibata Y*, Malhotra A, Dutta A (2009) A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). Genes Dev 23(22): 2639-2649 (* co-first authors) [13.623; 370]

13. Lee YS, Dutta A (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21(9): 1025-1030 [15.050; 1019]
- Highlighted in Genes and Dev. Vol. 21, No.9 (Perspectives in this issue “Oncogenic HMGA2: short or small?” page 1005-1009)

14. Kim HK*, Lee YS*, Sivaprasad U, Malhotra A, Dutta A (2006) Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 174(5): 677-687 (* co-first authors) [10.951; 589]
- Cover image of J. Cell Biol. Vol. 174, No.5
- Highlighted in J. Cell Biol. Vol. 174, No.5 (News in this issue “miRNAs halt cell cycle” page 608)
- Highlighted in Nature Vol. 443, No.7107 (Research highlights in this issue “Cell Biology: Muscle building made easy” page 4)

15. Lee YS, Kim HK, Chung S, Kim KS, Dutta A (2005) Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation. J Biol Chem 280(17): 16635-16641 [6.355; 366]

16. Lee YS, Han JS, Jeon Y, Hwang DS (2001) The arc two-component signal transduction system inhibits in vitro Escherichia coli chromosomal initiation. J Biol Chem 276(13): 9917-9923 [7.368; 38]

17. Lee YS, Lee H, Yim J, Hwang D (1997) The binding of two dimers of IciA protein to the dnaA promoter 1P element enhances the binding of RNA polymerase to the dnaA promoter 1P. Nucleic Acids Res 25(17): 3486-3489 [4.488; 9]

18. Lee YS, Hwang DS (1997) Occlusion of RNA polymerase by oligomerization of DnaA protein over the dnaA promoter of Escherichia coli. J Biol Chem 272(1): 83-88 [7.452; 34]

19. Lee YS, Kim H, Hwang DS (1996) Transcriptional activation of the dnaA gene encoding the initiator for oriC replication by IciA protein, an inhibitor of in vitro oriC replication in Escherichia coli. Mol Microbiol 19(2): 389-396 [5.024; 31]

REVIEWS, COMMENTARIES, AND BOOK CHAPTERS:

1. Park JL, Lee YS, Kunkeaw N, Kim SY, Kim IH, Lee YS (2017) Epigenetic regulation of noncoding RNA transcription by mammalian RNA polymerase III. Epigenomics 9: 171-187 [4.044; 0]

2. Fu Y, Lee I, Lee YS*, Bao X* (2015) Small non-coding transfer RNA-derived RNA Fragments (tRFs): their biogenesis, function and implication in human diseases. Genomics Inform 13(4): 94-101 [0.119; 0] (* co-corresponding authors)

3. Lee YS (2015) A novel type of non-coding RNA, nc886, implicated in tumor sensing and suppression. Genomics Inform 13(2): 26-30 [0.119; 0]

4. Jeon SH, Johnson BH, Lee YS (2012) A tumor surveillance model: a non-coding RNA senses neoplastic cells and its protein partner signals cell death. Int J Mol Sci 13(10): 13134-13139 [2.600; 2]

5. Comment in The Digest (2009) Tweaking tumors with microRNAs. Hum Gene Ther 20: 794

6. Lee YS, Dutta A (2009) MicroRNAs in cancer. Annu Rev Pathol 4: 199-227 [7.529; 367]

7. Lee YS, Dutta A (2006) MicroRNAs: small but potent oncogenes or tumor suppressors. Curr Opin Investig Drugs 7(6): 560-564 [3.324; 80]
list

top